N 6 -methyladenosine modification regulates cell death in cognitive impairment

Area of Science:

• Neuroscience
• Epigenetics
• Molecular Biology

Background:

• Neurodegenerative diseases involve brain structure and function decline.
• Cell death pathways like ferroptosis, cuproptosis, and pyroptosis are implicated.
• N6-methyladenosine (m6A) is a key RNA modification in the brain.

Purpose of the Study:

• To review the correlation between m6A modification and cell death patterns in neurodegenerative diseases.
• To explore the molecular mechanisms linking m6A epigenetic regulation to ferroptosis, cuproptosis, and pyroptosis.
• To highlight m6A's role in cognitive impairment and nerve regeneration.

Main Methods:

• Literature review of studies on m6A modification and neurodegeneration.
• Analysis of molecular mechanisms connecting m6A to ferroptosis, cuproptosis, and pyroptosis.
• Examination of m6A's dual role in nerve injury and regeneration.

Main Results:

• m6A modification is aberrantly regulated in neurodegenerative diseases.
• m6A intricately interacts with ferroptosis, cuproptosis, and pyroptosis pathways.
• m6A plays a dual role in nerve injury and regeneration, influencing the death-regeneration balance.

Conclusions:

• m6A epigenetic regulation is closely linked to the pathogenesis of neurodegenerative diseases.
• Interactions between m6A and cell death pathways present potential therapeutic targets.
• Targeting m6A modification could offer novel strategies for treating neurological disorders.